A Study of the Safety and Efficacy of Synvisc in Patients With Symptomatic Shoulder Osteoarthritis

This clinical study is to evaluate the safety and efficacy of Synvisc in patients with symptomatic shoulder osteoarthritis (OA). Patients will be given Synvisc, with the possible administration of a second injection where insufficient symptomatic pain relief was experienced during the 3 month follow up period.

Inclusion Criteria:

• Patients with symptomatic OA pain of shoulder (gleno-humeral)

Exclusion Criteria:

• Patients with current or prior conditions or treatment that would impede measurement of efficacy or safety